Vertiv Stock Soars Amidst 'Cramer Curse' Speculation and AI-Driven Demand
Money

Vertiv Stock Soars Amidst 'Cramer Curse' Speculation and AI-Driven Demand

authorBy Ramit Sethi
DateMar 16, 2026
Read time3 min

Vertiv Holdings (VRT) stock is demonstrating significant positive momentum. This surge in value follows a social media post by CNBC's Jim Cramer, where he characterized the company's shares as 'undervalued.' This pronouncement has reignited discussions surrounding the satirical 'Cramer Curse,' a popular belief that stocks praised by the television personality tend to falter. Nevertheless, analysts are maintaining a bullish outlook on Vertiv, largely due to its pivotal role in providing essential infrastructure for the burgeoning artificial intelligence sector.

Details of the Vertiv Stock Movement

On Monday, March 16, 2026, Vertiv Holdings shares observed an increase in trading activity. The catalyst appears to be a recent social media update from Jim Cramer, in which he shared a self-portrait in front of the Vertiv corporate logo, accompanied by the assertion that the company is 'undervalued.' This commentary has brought the stock into the spotlight, particularly given the widespread meme suggesting a contrarian view to Cramer's endorsements, often manifesting in the form of the Inverse Cramer Tracker ETF (SJIM), an exchange-traded fund designed to bet against his recommendations.

Cramer's optimistic assessment aligns with Vertiv's strong market position. The company is a key provider of power, cooling, and IT infrastructure systems crucial for data centers. This sector is currently experiencing explosive growth, driven by the escalating demand from cloud service providers and hyperscalers who are rapidly expanding their capacity to support artificial intelligence training and inference operations.

From a technical analysis perspective, Vertiv's stock is performing robustly. It is trading at 4.9% above its 20-day simple moving average and 37.1% above its 100-day simple moving average, indicating a sustained uptrend. Over the past year, shares have climbed an impressive 197.37%, hovering closer to their 52-week peak of $276.78 than their low of $53.60. The Relative Strength Index (RSI) stands at 60.63, residing in neutral yet bullish territory, while the Moving Average Convergence Divergence (MACD) shows a slight consolidation trend, yet within a broader upward trajectory. Key resistance is identified at $276.50, with support at $234.50.

Leading financial institutions have also weighed in, with RBC Capital, Citigroup, and Goldman Sachs all reiterating 'Buy' or 'Outperform' ratings for Vertiv in February, with target prices ranging from $266.00 to $286.00. Benzinga Edge's scorecard further highlights Vertiv's robust growth, quality, and momentum, although it notes a 'Weak' value score, suggesting that the current market valuation incorporates aggressive growth expectations. At the time of publication, Vertiv shares were up 2.41% to $265.12, nearing their 52-week high.

Market Insights and Future Outlook

The recent performance of Vertiv Holdings underscores the profound impact of artificial intelligence on various industries. As the demand for AI workloads continues to surge, companies providing the foundational infrastructure, like Vertiv, are likely to experience sustained growth. While the 'Cramer Curse' adds an interesting speculative layer, the underlying fundamentals of Vertiv – strong growth, high-quality offerings, and significant market momentum – suggest that its upward trajectory is rooted in genuine market demand. Investors should remain mindful of the "High-Flyer" characteristics identified by Benzinga Edge, indicating that while the stock has immense potential, sharp pullbacks could occur if market expectations cool or the broader technology sector experiences a downturn. This situation highlights the balance between capitalizing on emerging technological trends and managing inherent market volatilities.

More Articles
Canada Pension Plan to Divest $1.5B in Asian Private Equity Holdings
The Canada Pension Plan Investment Board (CPPIB) is reportedly planning to offload approximately $1.5 billion worth of its private equity investments concentrated in Asia. This strategic move aims to reduce the pension fund's exposure to Asian private equity. The divestment includes stakes in funds managed by prominent firms like Hillhouse Investment, Bain Capital, and PAG. This initiative aligns with CPPIB's broader shift away from direct buyout strategies towards external managers and co-investments.
By Chika UwazieMar 16, 2026
Micron's AI Memory Momentum Forecast to Endure for Years
Analysts Krish Sankar of TD Cowen and Srini Pajjuri of RBC Capital have both raised their price targets for Micron Technology, citing robust demand for AI memory and strong pricing trends. They anticipate significant earnings growth, driven by high-bandwidth memory (HBM) and data center needs, with a positive outlook extending through 2027 despite potential market corrections.
By Ramit SethiMar 16, 2026
Elon Musk Predicts SpaceX Will Surpass DeepMind in AI Leadership
Elon Musk has boldly declared that SpaceX will eventually overshadow Google DeepMind in the artificial intelligence domain, suggesting that the future of AI leadership may extend beyond traditional research labs. This perspective highlights the potential for companies with extensive technological infrastructure, like SpaceX with its Starlink network, to emerge as dominant forces in developing large-scale AI systems, fundamentally reshaping the competitive landscape of the AI industry.
By Scott PapeMar 16, 2026
Global Market Dynamics and Portfolio Adjustments: March 2026
This report analyzes the evolving global market landscape in March 2026, characterized by geopolitical tensions, cautious central bank policies, and government fiscal interventions. It explores economic conditions across Europe, the UK, Japan, Asia, and North America, and details specific company performances and strategic adjustments within a model stock portfolio, emphasizing resilience in the face of macro-economic shifts.
By Dave RamseyMar 16, 2026
Unpacking Eli Lilly's Valuation: Is the Market Overly Optimistic?
Eli Lilly has experienced remarkable growth propelled by its GLP-1 medications, Zepbound and Mounjaro. While its market capitalization approaches $900 billion, questions arise regarding whether its stock valuation is excessively high. This analysis explores the factors driving investor bullishness and examines potential risks, including future competition and the impact of a premium price on investor safety, despite the company's strong performance and promising pipeline.
By T. Harv EkerMar 16, 2026